Zurich Insurance Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-43,656
| Closed | -$4.28M | – | 504 |
|
|
2019
Q3 | $4.28M | Buy |
43,656
+1,442
| +3% | +$141K | 0.08% | 267 |
|
|
2019
Q2 | $5.53M | Buy |
+42,214
| New | +$5.53M | 0.11% | 227 |
|
|
2018
Q2 | – | Sell |
-49,299
| Closed | -$5.5M | – | 558 |
|
|
2018
Q1 | $5.5M | Buy |
49,299
+15,229
| +45% | +$1.7M | 0.13% | 219 |
|
|
2017
Q4 | $4.07M | Buy |
34,070
+4,181
| +14% | +$500K | 0.1% | 258 |
|
|
2017
Q3 | $4.19M | Sell |
29,889
-1,390
| -4% | -$195K | 0.11% | 212 |
|
|
2017
Q2 | $3.81M | Sell |
31,279
-619
| -2% | -$75.3K | 0.11% | 237 |
|
|
2017
Q1 | $3.87M | Buy |
31,898
+2,577
| +9% | +$312K | 0.11% | 230 |
|
|
2016
Q4 | $3.59M | Buy |
29,321
+189
| +0.6% | +$23.1K | 0.11% | 227 |
|
|
2016
Q3 | $3.57M | Buy |
29,132
+6,196
| +27% | +$759K | 0.12% | 207 |
|
|
2016
Q2 | $2.68M | Sell |
22,936
-11,644
| -34% | -$1.36M | 0.09% | 235 |
|
|
2016
Q1 | $4.81M | Buy |
34,580
+12,298
| +55% | +$1.71M | 0.17% | 162 |
|
|
2015
Q4 | $4.25M | Buy |
+22,282
| New | +$4.25M | 0.15% | 167 |
|